A. Boyer et al. / Tetrahedron 66 (2010) 6468e6482
6479
(dd, J¼7.0, 1.5 Hz, 2H), 7.57e7.44 (m, 4H), 7.38 (ddd, J¼7.8, 7.3,
1.7 Hz, 1H), 7.34 (d, J¼7.3, 6.9, 1.4 Hz, 1H), 6.62 (d, J¼16.0 Hz, 1H),
1.56 (s, 9H); dC (100 MHz; CDCl3): 166.6, 157.3, 154.5, 134.8, 129.8,
129.6, 128.9, 128.5, 126.9, 125.2, 123.6, 121.1, 121.1, 112.7, 111.5,
80.5, 28.3.
1088, 1034, 1011 cmꢂ1; m/z (ESI) 372.1233 (MþþNa: C18H23NO4SNa
requires 372.1240).
4.6. Typical domino reaction with 2-cyclohexene
A solution of [Rh(cod)OH]2 (4 mg, 3 mol %, 6 mol % Rh) and
Tol-BINAP (12 mg, 6 mol %) in dioxaneewater (1 cm3, 10:1) was
stirred at room temperature for 0.5 h. A solution of phenol 16a
(50 mg, 0.29 mmol) and 2-cyclohexenone (0.14 cm3, 1.4 mmol) in
dioxane (1 cm3) was added and the mixture was heated to 90 ꢀC
for 6 h. The reaction was cooled to room temperature, diluted
with Et2O (5 cm3) and filtered through a short pad of silica,
washing with Et2O (4ꢁ5 cm3). The filtrate was concentrated un-
der reduced pressure and purified by column chromatography
(gradient from 0 to 3% Et2O in pentane) to give 17a (7 mg, 14%)
followed by 42a (1 mg, 2%), then 41a (24 mg, 47%) and 40a (3 mg,
9%) all as pale yellow oils.
4.5.9. 3-(2-n-Butyl-1-methanesulfonylindol-3-yl)propionitrile (35e)
and 3-(2-n-butyl-1-methanesulfonylindol-3-yl)acrylonitrile (36e).
Subjecting aniline 67 (50 mg, 0.20 mmol) with acrylonitrile
(0.13 ml, 2.0 mmol) to general procedure B followed by chroma-
tography (gradient from 9 to 25% EtOAc in hexane) gave 35e
(53 mg, 88%) as a white solid and 36e (2 mg, 3%) as a white solid.
Compound 35e: mp¼100e101 ꢀC; dH (400 MHz; CDCl3): 8.08e8.03
(m, 1H), 7.46e7.41 (m, 1H), 7.36e7.29 (m, 2H), 3.07 (t, J¼7.3 Hz, 2H),
2.99 (t, J¼7.6 Hz, 2H), 2.96 (s, 3H), 2.67 (t, J¼7.3 Hz, 2H), 1.72e1.63
(m, 2H), 1.42 (app. sextet, J¼7.4 Hz, 2H), 0.96 (t, J¼7.4 Hz, 3H); dC
(100 MHz; CDCl3): 139.6, 136.4, 129.3, 124.7, 123.9, 118.8, 117.9,
116.7, 114.9, 40.0, 33.1, 26.0, 22.7, 20.4, 17.9, 13.8; nmax 2959, 2932,
2872, 2247, 1607, 1454, 1362, 1329, 1242, 1171, 1082 cmꢂ1; m/z (EI)
304.1251 (Mþ: C16H20N2O2S requires 304.1245). 36e:
mp¼116e118 ꢀC; dH (400 MHz; CDCl3): 8.11e8.06 (m, 1H),
7.74e7.69 (m, 1H), 7.54 (d, J¼16.7 Hz, 1H),7.427.37 (m, 2H), 5.98 (d,
J¼16.7 Hz, 1H), 3.12 (s, 3H), 3.08 (t, J¼7.4 Hz, 2H), 1.72e1.64 (m, 2H),
1.50e1.41 (m, 2H), 0.97 (t, J¼7.4 Hz, 3H); dC (100 MHz; CDCl3):
145.1, 141.4, 136.2, 126.6, 125.4, 124.8, 119.6, 118.8, 115.2, 114.6, 96.4,
41.4, 33.3, 26.0, 22.7, 13.7; nmax 2959, 2932, 2872, 2214, 1616, 1452,
4.6.1. 3-(2-Butylbenzofuran-3-yl)cyclohexanone (40a). The analyti-
cal data were in agreement with literature values.16 dH (400 MHz;
CDCl3): 7.62e7.59 (m, 1H), 7.44e7.40 (m, 1H), 7.26e7.17 (m, 2H),
3.14 (dddd, J¼12.9, 12.9, 3.8, 3.8 Hz, 1H), 2.93 (t, J¼13.7 Hz, 1H), 2.73
(t, J¼7.5 Hz, 2H), 2.57e2.42 (m, 3H), 2.35e2.19 (m, 2H), 2.04e1.97
(m, 1H), 1.88e1.74 (m, 1H), 1.72e1.64 (m, 2H), 1.42e1.32 (m, 2H),
0.94 (t, J¼7.4 Hz, 3H); dC (100 MHz; CDCl3): 210.60, 154.14, 154.12,
127.63, 123.10, 121.94, 119.55, 116.12, 111.15, 47.40, 41.29, 36.44,
31.03, 30.65, 26.26, 25.85, 22.30, 13.78.
1368, 1329, 1175, 1090 cmꢂ1
C16H19N2O2S requires 303.1161).
;
m/z (ESI) 303.1165 (MþþH:
4.6.2. (E)-2-(2-n-Butyl-2-(2-n-butylbenzofuran-3-yl)vinyl)phenol
(41a). dH (400 MHz; CDCl3): 7.54e7.51 (m, 1H), 7.45e7.42 (m, 1H),
7.27e7.19 (m, 4H), 6.99e6.93 (m, 2H), 6.45 (s, 1H), 5.00 (s, 1H), 2.87
(dd, J¼7.5, 7.8 Hz, 2H), 2.54 (dd, J¼7.8, 7.2 Hz, 2H), 1.82e1.74 (m, 2H),
1.44 (ddt, J¼14.7, 7.3, 7.4 Hz, 2H), 1.33e1.16 (m, 4H), 0.96 (t, J¼7.4 Hz,
3H), 0.74 (t, J¼7.2 Hz, 3H); dC (100 MHz;CDCl3): 155.50,153.79,152.96,
139.39, 129.74, 128.78, 128.69, 124.02, 124.00, 123.37, 122.41, 120.33,
119.58, 117.56, 115.18, 110.83, 31.28, 30.63, 30.58, 26.83, 22.56, 22.49,
13.84, 13.72; m/z (EI) 348.2094 (Mþ: C24H28O2 requires 348.2089).
4.5.10. 1-(2-n-Butyl-1-methanesulfonylindol-3-yl)pentan-3-one
(37e). Subjecting aniline 21e (47 mg, 0.19 mmol) with ethyl vinyl
ketone (0.19 ml, 1.9 mmol) to general procedure C followed by
chromatography (gradient from 10 to 17% EtOAc in hexane) gave
the title compound (60 mg, 94%) as a white solid. mp¼58e59 ꢀC; dH
(400 MHz; CDCl3): 8.04e7.99 (m, 1H), 7.47e7.43 (m, 1H), 7.32e7.27
(m, 2H), 2.98e2.93 (m, 4H), 2.92 (s, 3H), 2.71 (t, J¼7.7 Hz, 2H), 2.42
(q, J¼7.3 Hz, 2H), 1.63 (app. quintet, J¼7.5 Hz, 2H), 1.41 (app. sextet,
J¼7.5 Hz, 2H), 1.06 (t, J¼7.3 Hz, 3H), 0.94 (t, J¼7.5 Hz, 3H); dC
(100 MHz; CDCl3): 210.3, 138.1, 136.3, 130.2, 124.2, 123.6, 119.4,
118.4, 114.6, 42.0, 39.8, 36.1, 33.0, 25.8, 22.7, 18.3, 13.8, 7.7; nmax
2959, 2934, 2872, 1713, 1607, 1454, 1412, 1362, 1240, 1171, 1153,
1113, 1067, 964 cmꢂ1; m/z (ESI) 336.1645 (MþþH: C18H26NO3S re-
quires 336.1627).
4.6.3. (E)-2-(1-(2-n-Butyl-benzofuran-3-yl)hex-1-enyl)phenol
(42a). dH (400 MHz; CDCl3): 7.38 (d, J¼8.1 Hz, 1H), 7.28e7.16 (m,
3H), 7.12 (td, J¼7.8, 1.0 Hz, 1H), 7.04 (dd, J¼7.6, 1.7 Hz, 1H), 6.97 (dd,
J¼8.2, 1.1 Hz, 1H), 6.88 (ddd, J¼7.5, 7.5, 1.2 Hz, 1H), 6.18 (t, J¼7.5 Hz,
1H), 5.28 (s, 1H), 2.58 (t, J¼7.6 Hz, 2H), 2.22e2.16 (m, 2H), 1.62e1.24
(m, 8H), 0.91e0.83 (m, 6H).
4.5.11. 3-(2-n-Butyl-1-methanesulfonylindol-3-yl)propionic
acid
ethyl ester (38e) and 3-(2-n-butyl-1-methane sulfonylindol-3-yl)
acrylic acid ethyl ester (39e). Subjecting aniline 21e (48 mg,
0.19 mmol) and ethyl acrylate (0.042 cm3, 0.39 mmol) to general
procedure C followed chromatography (gradient from 9 to 17% Et2O
in hexane) to give 38e and 39e (59.9 mg, 89%, >40:1 37e/39e by 1H
NMR). Compound 38e: colourless oil. dH (400 MHz; CDCl3):
8.04e7.99 (m, 1H), 7.52e7.47 (m, 1H), 7.32e7.27 (m, 2H), 4.13 (q,
J¼7.2 Hz, 2H), 3.01 (t, J¼8.0 Hz, 2H), 2.95 (t, J¼7.8 Hz, 2H), 2.92 (s, 3H),
2.60 (t, J¼8.0 Hz, 2H), 1.67e1.61 (m, 2H), 1.41 (app. sextet, J¼7.4 Hz,
2H),1.24 (t, J¼7.2 Hz, 3H), 0.95 (t, J¼7.4 Hz, 3H); dC (100 MHz; CDCl3):
172.7, 138.4, 136.4, 130.2, 124.3, 123.6, 119.1, 118.5, 114.6, 60.6, 39.8,
34.4, 33.0, 25.9, 22.7,19.7,14.2,13.8; nmax 2959, 2932, 2872,1732,1607,
1454,1362,1242,1171,1119,1080,1047,1020 cmꢂ1; m/z (ESI) 352.1586
(MþþH: C18H26NO4S requires 352.1577). 39e: white solid.
Mp¼132e133 ꢀC; dH (400 MHz; CDCl3): 8.10e8.05 (m,1H), 7.90e7.84
(m,1H), 7.88 (d, J¼16.2 Hz,1H), 7.39e7.34 (m, 2H), 6.58 (d, J¼16.2 Hz,
1H), 4.30 (q, J¼7.2 Hz, 2H), 3.15 (t, J¼7.8 Hz, 2H), 3.09 (s, 3H),
1.74e1.62 (m, 2H), 1.50e1.39 (m, 2H), 1.37 (t, J¼7.2 Hz, 3H), 0.96 (t,
J¼7.4 Hz, 3H); dC (100 MHz; CDCl3): 167.4, 144.8, 136.3, 135.3, 127.5,
125.0, 124.5, 120.2, 118.7, 115.9, 114.4, 60.5, 41.0, 33.2, 25.9, 22.6, 14.4,
13.7; nmax 2959, 2932, 2874, 1705, 1628, 1452, 1366, 1306, 1277, 1169,
4.6.4. (1,2,3,4-Tetrahydrodibenzofuran-1-yl)acetic acid methyl ester
(40m) and 6-benzofuran-2-ylhex-2-enoic acid methyl ester (17m).
Subjecting phenol 16m (42 mg, 0.17 mmol) to general procedure C
(with DME in place of dioxane) followed by chromatography (gra-
dient from 5 to 20% Et2O in hexane) gave 40m (30 mg, 70%) as
a colourless oil, followed by 17m (3 mg, 8%) as a colourless oil. 40m:
dH (400 MHz; CDCl3): 7.45, (dd, J¼7.2, 1.7 Hz, 1H), 7.40, (dd, J¼7.6,
1.6 Hz, 1H), 7.21 (ddd, J¼7.6, 7.4, 1.7 Hz, 1H), 7.18 (ddd, J¼7.4, 7.2,
1.6 Hz, 1H), 3.72 (s, 3H), 3.50e3.42 (m, 1H), 2.94 (dd, J¼15.4, 4.3 Hz,
1H), 2.78e2.68 (m, 2H), 2.42 (dd, J¼15.4, 10.1 Hz, 1H), 2.02e1.85 (m,
3H), 1.76e1.67 (m, 1H); dC (100 MHz; CDCl3): 173.1, 154.4, 154.4,
127.6, 123.1, 122.2, 118.8,114.9, 111.0, 51.6, 38.9, 29.0, 28.3, 23.4, 19.5;
nmax 2945, 1738, 1634, 1476, 1454, 1435, 1360, 1269, 1192, 1167, 1071,
1013 cmꢂ1; m/z (ESI) 267.1004 (MþþNa): C15H16O3Na requires
267.0991. Compound 17m: dH (400 MHz; CDCl3): 7.48 (dd, 7.5,
1.6 Hz, 1H), 7.41 (dd, 7.8, 1.2 Hz, 1H), 7.21 (ddd, J¼7.8, 7.2, 1.6 Hz, 1H),
7.18 (ddd, J¼7.5, 7.2, 1.2 Hz, 1H), 6.98 (dt, J¼15.6, 7.0 Hz, 1H), 6.39 (s,
1H), 5.86 (dt, J¼15.6, 1.5 Hz, 1H), 3.73 (s, 3H), 2.80 (t, J¼7.2 Hz, 2H),
2.31 (ddt, J¼7.6, 7.0, 1.5 Hz, 2H), 1.93 (tt, J¼7.6, 7.2 Hz, 2H); dC
(100 MHz; CDCl3): 167.0, 158.3, 154.7, 148.4, 128.8, 123.2, 122.5,
121.6, 120.2, 110.7, 102.4, 51.4, 31.4, 27.7, 26.0; nmax 2949, 1728, 1659,